Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type
James R. Hilser, N. Sṕencer, Kimia Moeeni Afshari, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 11, pp. 2321-2333
Closed Access | Times Cited: 7
Marked Global Differences in Mortality in Male Patients with COVID-19: An Analysis of the CARDIO COVID 19–20 and WHF COVID-19 CVD Studies
Juan Esteban Gómez‐Mesa, Juan Pablo Arango-Ibañez, Pablo Perel, et al.
Global Heart (2025) Vol. 20, Iss. 1
Open Access
Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Platelet Morphology and Activation
Marco Vettori, Giovanni Carpenè, Gian Luca Salvagno, et al.
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 02, pp. 275-283
Closed Access | Times Cited: 10
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries
Denise Battaglini, Thu‐Lan Kelly, Matthew Griffee, et al.
Heart & Lung (2024) Vol. 68, pp. 131-144
Closed Access | Times Cited: 3
COVID-19 and cardiovascular disease in patients with chronic kidney disease
Lucia Del Vecchio, Olga Balafa, Evangelia Dounousi, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 2, pp. 177-189
Open Access | Times Cited: 8
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management
Richard C. Becker, Udaya S. Tantry, Muhammad H Khan, et al.
Journal of Thrombosis and Thrombolysis (2024)
Open Access | Times Cited: 2
Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue
Valentin Varlas, Roxana Georgiana Borş, Mihaela Plotogea, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1949-1949
Open Access | Times Cited: 7
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry
Dimitrios Giannis, Mark Goldin, Husneara Rahman, et al.
Thrombosis and Haemostasis (2023) Vol. 123, Iss. 11, pp. 1089-1099
Closed Access | Times Cited: 7
Comparative analysis of compartment-specific immunothrombotic biomarker profiles in bronchoalveolar lavage fluid and serum of patients with pneumonia-related acute respiratory distress syndrome: A preliminary cross-sectional study
Xiaolong Zong, Xuechao Wang, Yaru Liu, et al.
Journal of Investigative Medicine (2024)
Closed Access | Times Cited: 1
Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19
Chiara E. Geyer, Hung‐Jen Chen, Alexander P. Bye, et al.
Life Science Alliance (2023) Vol. 6, Iss. 11, pp. e202302106-e202302106
Open Access | Times Cited: 4
Aspirin and P2Y12 inhibitors in treating COVID-19
Amirmohammad Khalaji, Amir Hossein Behnoush, Soheil Peiman
European Journal of Internal Medicine (2022) Vol. 110, pp. 101-103
Open Access | Times Cited: 5
Platelets in COVID-19 disease: friend, foe, or both?
Marta Smęda, Ebrahim H. Maleki, Agnieszka Pełesz, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1182-1197
Open Access | Times Cited: 5
Antithrombotic Use Patterns in COVID-19 Patients from Spain: A Real-World Data Study
Karen Lizzette Ramírez-Cervantes, Salvador Campillo-Morales, Patricia García-Poza, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2403-2403
Open Access
COVID-19 and platelets: an enigmatic relationship
Giuseppe Lippi, Fabián Sanchis‐Gomar
Elsevier eBooks (2024), pp. 129-134
Closed Access
Effect of Aspirin Use on the Adverse Outcomes in Patients Hospitalized for COVID-19
Poornima Vinod, Vinod Krishnappa, William Rathell, et al.
Cardiology Research (2024) Vol. 15, Iss. 3, pp. 179-188
Open Access
Effects of the circulating environment of COVID-19 on platelet and neutrophil behavior
Alexander T. Fields, Elizabeth Andraska, Christof Kaltenmeier, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19
Chiara E. Geyer, Hung‐Jen Chen, Alexander P. Bye, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Spatially Distinct Immunothrombotic Signatures in Patients with Pneumonia-Related Acute Respiratory Distress Syndrome: Insights from Lung Alveolar and Blood Circulation Profiles
Xiaolong Zong, Liying Geng, Yaru Liu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top